Vered Schechner

2.0k citations

47 papers · 1.3k indexed · h-index 15

Impact in

Applied Microbiology and Biotechnology top 0.5%
- Antibiotic Use and Resistance
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 14
- Antibiotic Use and Resistance 14
Molecular Medicine 21
- Antibiotic Resistance in Bacteria 21

Co-authors: Yehuda Carmeli Mitchell J. Schwaber Shiri Navon‐Venezia David A. Schwartz Elizabeth Temkin Inna Chmelnitsky Stéphan Harbarth Amos Adler
Journals: Infection Control and Hospital Epidemiology (8 papers)Antimicrobial Resistance and Infection Control (3 papers)Journal of Hospital Infection (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Clinical Microbiology and Infection (2 papers)
Partner nations: Israel United States Switzerland

In The Last Decade

Vered Schechner

44 papers receiving 1.3k citations

Peers

Countries citing papers authored by Vered Schechner

Since Specialization

Citations

This map shows the geographic impact of Vered Schechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vered Schechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vered Schechner more than expected).

Fields of papers citing papers by Vered Schechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vered Schechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vered Schechner. The network helps show where Vered Schechner may publish in the future.

Co-authors

The 25 scholars most cited alongside Vered Schechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vered Schechner Line = papers co-authored together Vered Schechner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A benchmarking study of thirty-day mortality following Staphylococcus aureus or Escherichia coli bacteremia Journal of Infection ·Elizabeth Temkin, B. B. J. Frericks, 안승찬, Dimple Chudasama, Vered Schechner, Amir Nutman, Mitchell J. Schwaber, Yehuda Carmeli	2025	0
2	Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trial Trials ·Bianca Albers, Eric Calderon, Кутузов Андрей Александрович, Greet J. Boland, Elena Carrara, Pilar Retamar, Aude Nguyen, Amine Beyhom, Vered Schechner, Bejamin Weigel, Takuya Yanagida, Walter Zingg, Sylvia de Agular	2025	0
3	Tailoring Interventions for Control of Endemic Carbapenem-Resistant Acinetobacter baumannii: An Interrupted Time Series Analysis Open Forum Infectious Diseases ·Vered Schechner, Adi Cohen, Yehuda Carmeli	2024	2
4	Identification and control of two outbreaks of unrelated New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli traced to the same endoscope defect Infection Control and Hospital Epidemiology ·J. Jesús Alcazar-Andrade, Vered Schechner, 一貴高橋, Iyad Khamaysi, Анна Володимирівна Явтушенко, Mor N. Lurie-Weinberger, Henriksson Sofie, Julia Nsa Asumu Oyana, Yuval Geffen, Khetam Hussein	2023	2
5	Carbapenem-resistant Acinetobacter baumannii load in patients and their environment: the importance of detecting carriers Infection Control and Hospital Epidemiology ·Vered Schechner, A. Lerner, Elizabeth Temkin, Yehuda Carmeli	2023	5
6	Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel Microorganisms ·Amir Nutman, Elizabeth Temkin, Lei Huadong, Vered Schechner, Mitchell J. Schwaber, Yehuda Carmeli	2023	5
7	Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel Infection Control and Hospital Epidemiology ·Mitchell J. Schwaber, Elizabeth Temkin, Minghan Sun, Vered Schechner, Amir Nutman, Yehuda Carmeli	2022	3
8	One-year mortality and years of potential life lost following bloodstream infection among adults: A nation-wide population based study The Lancet Regional Health - Europe ·Vered Schechner, B. B. J. Frericks, Elizabeth Temkin, Sarah Feldman, Amir Nutman, Pnina Shitrit, Mitchell J. Schwaber, Yehuda Carmeli	2022	20
9	Carriage of vancomycin-resistant Enterococcus faecium in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization Infection Control and Hospital Epidemiology ·Vered Schechner, Jonathan Lellouche, D. Naylor, Dror Mandel, Galia Grisaru‐Soen, Ş. Sfarlos, David A. Schwartz, Yehuda Carmeli	2022	1
10	Investigation of Outbreaks of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae in Three Neonatal Intensive Care Units Using Whole Genome Sequencing Antibiotics ·Sammy Frenk, Guoxiong Shi, Elizabeth Temkin, Vered Schechner, Regev Cohen, Theo W Stull, Mitchell J. Schwaber, Ester Solter, 晴生笹山, D. Naylor, Yehuda Carmeli	2020	16
11	A silent outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit Antimicrobial Resistance and Infection Control ·Ronella Marom, Dror Mandel, Alon Haham, Rafael Pérez-Barreto, Maria Jamile Amaral Alves, Craig Raskind, Galia Grisaru‐Soen, Amos Adler, Jonathan Lellouche, David A. Schwartz, Yehuda Carmeli, Vered Schechner	2020	13
12	Environmental contamination by carbapenem-resistant Acinetobacter baumannii: The effects of room type and cleaning methods Infection Control and Hospital Epidemiology ·A. Lerner, Abdul Yusuf, Yehuda Carmeli, Vered Schechner	2019	14
13	Clinical benefits of FilmArray meningitis-encephalitis PCR assay in partially-treated bacterial meningitis in Israel BMC Infectious Diseases ·М. И. Старов, Vered Schechner, T. Felici, Dafna Yahav, Efraim Bilavsky, Nadav Sorek, Haim Ben‐Zvi, Amos Adler	2019	11
14	A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation PLoS ONE ·Vered Schechner, Yehuda Carmeli, Moshe Leshno	2017	5
15	Multidrug-Resistant Candida haemulonii and C. auris , Tel Aviv, Israel Emerging infectious diseases ·Ronen Ben‐Ami, Judith Berman, Alfred Rühl, Edna Bash, Yael Shachor‐Meyouhas, 张毛帝, ‪Yasmin Maor‬‏, Jean Louis Lejonc, Vered Schechner, Amos Adler, Talya Finn	2017	255
16	Clinical Characteristics of and Preventative Strategies for Peripartum Group A Streptococcal Infections Obstetrics and Gynecology ·Shiri Shinar, Yuval Fouks, Sharon Amit, David Pauzner, Jalal Tarabeia, Vered Schechner, Ariel Many	2016	12
17	Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer Journal of Hospital Infection ·Efraim Bilavsky, Y JACQUEMYN, Jalal Tarabeia, Vered Schechner, Abdul Yusuf, Galia Grisaru‐Soen, David A. Schwartz, Shiri Navon‐Venezia, Yehuda Carmeli	2013	8
18	Transfer of Carbapenem-Resistant Plasmid fromKlebsiella pneumoniaeST258 toEscherichia coliin Patient Emerging infectious diseases ·Moran G. Goren, Yehuda Carmeli, Mitchell J. Schwaber, Inna Chmelnitsky, Vered Schechner, Shiri Navon‐Venezia	2010	116
19	Gram‐Negative Bacteremia upon Hospital Admission: When Should Pseudomonas aeruginosa Be Suspected? Clinical Infectious Diseases ·Vered Schechner, Vandack Nobre, Keith S. Kaye, Moshe Leshno, Michael Giladi, Peter Rohner, Stephan Harbarth, Deverick J. Anderson, Adolf W. Karchmer, Mitchell J. Schwaber, Yehuda Carmeli	2009	54
20	Head or tail? Nephrology Dialysis Transplantation ·Tiberiu Hershcovici, Teresa Calderón Casero, Vered Schechner, Ana Tobar, Yitzhak Beigel	2003	1

About Vered Schechner

Vered Schechner is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Endocrinology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Antibiotic Use and Resistance (14 papers), Nosocomial Infections in ICU (6 papers), Blood properties and coagulation (5 papers), Vibrio bacteria research studies (5 papers), Pneumonia and Respiratory Infections (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (298 citations), Molecular Medicine (638 citations), Endocrinology (233 citations), Clinical Biochemistry (218 citations) and Infectious Diseases (411 citations). Vered Schechner has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Yehuda Carmeli, Mitchell J. Schwaber, Shiri Navon‐Venezia, David A. Schwartz, Elizabeth Temkin, Inna Chmelnitsky, Stéphan Harbarth, Amos Adler, Ronen Ben‐Ami and M. Kazma. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Resistance and Infection Control, Journal of Hospital Infection, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact